A detailed history of Trifecta Capital Advisors, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 231 shares of BDX stock, worth $54,095. This represents 0.01% of its overall portfolio holdings.

Number of Shares
231
Previous 121 90.91%
Holding current value
$54,095
Previous $29.9 Million 80.31%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$225.07 - $246.17 $24,757 - $27,078
110 Added 90.91%
231 $54 Million
Q1 2024

Apr 16, 2024

SELL
$233.45 - $247.73 $7,236 - $7,679
-31 Reduced 20.39%
121 $29.9 Million
Q4 2023

Jan 25, 2024

BUY
$232.24 - $267.23 $7,199 - $8,284
31 Added 25.62%
152 $37.1 Million
Q4 2022

Jan 17, 2023

BUY
$218.29 - $256.91 $26,413 - $31,086
121 New
121 $30.8 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $66.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Trifecta Capital Advisors, LLC Portfolio

Follow Trifecta Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trifecta Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trifecta Capital Advisors, LLC with notifications on news.